Cidara Therapeutics, Inc. (CDTX)
221.38
0.00 (0.00%)
USD |
NASDAQ |
Feb 20, 16:00
Cidara Therapeutics SG&A Expense (Quarterly) : 8.099M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| Cogent Biosciences, Inc. | 23.93M |
| Olema Pharmaceuticals, Inc. | 5.926M |
| Rhythm Pharmaceuticals, Inc. | 52.42M |
| BridgeBio Pharma, Inc. | 137.62M |